Precision Biosciences Inc SEC filings DTIL

Precision Biosciences Inc has 606 filings in SEC EDGAR's recent list, going back to Mar 15, 2006. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (other events). The company's fiscal year ends on May 21.

Form Description Filed Period
ARS Annual report to shareholders Apr 8, 2026 Dec 31, 2025
10-K Annual report Mar 12, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 15, 2025 Dec 31, 2024
10-K Annual report Mar 26, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
10-K Annual report Mar 27, 2024 Dec 31, 2023
ARS Annual report to shareholders Mar 23, 2023 Dec 31, 2022
10-K Annual report Mar 9, 2023 Dec 31, 2022
10-K Annual report Mar 15, 2022 Dec 31, 2021
10-K Annual report Mar 18, 2021 Dec 31, 2020
10-K Annual report Mar 10, 2020 Dec 31, 2019

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
DTIL (Nasdaq)
Fiscal year ends
May 21
Incorporated in
DE
Headquarters
Durham, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1357874

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.